Mistletoe extract - Cancer
You are here : Home > Formulary Search > Mistletoe extract - Cancer
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Documentation
Policy Statement
Evidence Review
PAD Profile
ChemicalSubstance :
Mistletoe extract
Indication :
Cancer
Group Name :
Keywords :
mistletoe extract; semi-parasitic plant
Brand Names Include :
Iscador, Eurixor, Lektinol, cefalektin, AbnobaVISCUM, Helixor,Isorel, Iscucin
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
3
Other Indications
Below are listed other indications that Mistletoe extract is used to treat.
Committee Recommendations (2)
At the Surrey and North-West Sussex Area Prescribing Committee (APC) held in June 2020, it was decided that all BLACK status drugs would have their review dates extended for 5 years without the need for a review.
If a clinician or provider wishes to change the traffic light status of any BLACK drug then they will need to submit a paper for change as per usual APC process.
The PCN does not support the routine use of mistletoe extract for the treatment of cancer or palliative care.
Mistletoe extract will be considered as BLACK on the traffic light system.